Sartorius Stedim Biotech Overview

  • Founded
  • 1870
Founded
  • Status
  • Public
  • Employees
  • 6,900
Employees
  • Stock Symbol
  • DIM
Stock Symbol
  • Investments
  • 9
  • Share Price
  • $466.81
  • (As of Monday Closing)

Sartorius Stedim Biotech General Information

Description

Sartorius Stedim Biotech is the leading provider of tools for biopharmaceutical fermentation and fluid management. Parent Sartorius AG has a 74% stake in the company, with 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (40% of 2020 sales), the Americas (35%), and Asia-Pacific (25%). Sartorius Stedim Biotech employs over 7,500 people and has operations in more than 20 countries.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Holding Companies
Other Industries
Medical Supplies
Stock Exchange
PAR
Primary Office
  • August-Spindler-Straße 11
  • 37079 Goettingen
  • Germany
+49 0551 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sartorius Stedim Biotech Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$466.81 $463.18 $222.42 - $506.61 $43B 92.2M 70.1K $5.02

Sartorius Stedim Biotech Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 38,615,196 33,167,606 15,414,204 9,381,411
Revenue 2,496,978 2,177,326 1,612,639 1,430,420
EBITDA 813,913 673,942 442,250 411,927
Net Income 463,388 407,917 262,511 245,515
Total Assets 3,883,802 3,775,182 2,067,123 1,797,599
Total Debt 714,160 721,725 155,257 171,168
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sartorius Stedim Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sartorius Stedim Biotech‘s full profile, request access.

Request a free trial

Sartorius Stedim Biotech Executive Team (3)

Name Title Board Seat Contact Info
Rainer Lehmann Chief Financial Officer & member of the executive board
Bernard Lemaitre Founder & Chairman
Joachim Kreuzburg Chief Executive Officer & Chairman of the Board
To view Sartorius Stedim Biotech’s complete executive team members history, request access »

Sartorius Stedim Biotech Board Members (4)

Name Representing Role Since
0000000 00000000 Sartorius Stedim Biotech Founder & Chairman 000 0000
0000000 000000000 Self Chief Executive Officer & Chairman of the Board 000 0000
00000000 0000 Sartorius Board Member 000 0000
000é 0á000 Self Board Member 000 0000
To view Sartorius Stedim Biotech’s complete board members history, request access »

Sartorius Stedim Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sartorius Stedim Biotech Acquisitions (9)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 (000000000 06-Jan-2021 000000000000000000 Other Pharmaceuticals and Biotechnology 000é 0á000
00000000 03-Apr-2017 000000000000000000 0000 Business/Productivity Software 0000000 000000000
0000 0000000 29-Jul-2016 000000000000000000 000.00 Other Healthcare Technology Systems 00000000 0000
000000 01-Jul-2015 000000000000000000 000.00 Biotechnology
BioOutsource 17-Apr-2015 Merger/Acquisition 000.00 Other Commercial Services
You’re viewing 5 of 9 acquisitions. Get the full list »

Sartorius Stedim Biotech Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000000000 Other Commercial Products New Oxford, PA 0000
To view Sartorius Stedim Biotech’s complete subsidiaries history, request access »